Business Wire

Pulse Biosciences Presents Update on Nano-Pulse Stimulation™ Technology at Prestigous Energy-Based Devices and Aesthetic Dermatology Conference

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (NASDAQ:PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS™) technology, today announced that a scientific ...

Pulse Biosciences Initiates Patient Enrollment in NANOPULSE-AF Study

PLSE begins patient enrollment in NANOPULSE-AF pivotal study, advancing its NPS tech toward potential AF treatment approval ...

Spinal Cord Stimulation Devices Market to Reach $4.8 Billion by 2032; Chronic Pain Demand Drives 8.4% CAGR | Allied Market Research

Devices Market is entering an era of rapid technological advancement and extended clinical utility. According to a ...
Business Insider

Pulsetto Unveils Groundbreaking Vagus Nerve Stimulation Device at CES

Pulsetto, a leader in Vagus Nerve Stimulation technology, is showcasing at CES its unique dual-technology system and personalized app designed to alleviate stress, reduce anxiety, improve sleep, and ...
Insider Monkey

Pulse Biosciences, Inc. (PLSE) Advances Cardiac Care with FDA-Approved Atrial Fibrillation Trial

We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. Pulse Biosciences, Inc. is one of them. Pulse Biosciences, Inc. (NASDAQ:PLSE) is advancing bioelectric medicine ...
Medscape

Stimulation Device Improves Hand Function Post Spinal Cord Injury

A noninvasive spinal stimulation device safely improves upper-extremity function in people with a cervical spinal cord injury (SCI), results of a prospective nonsignificant risk trial suggest. The ...